Overview

Relapse Prevention to Reduce HIV Among Women Prisoners

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study is a feasibility and acceptability study assessing whether providing buprenorphine for women under criminal justice supervision leaving a controlled environment and returning to the community would prevent opioid relapse and reduce HIV risk behaviors.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine